$REPL
Replimune Group, Inc.
Nasdaq · Healthcare · Biological Products, (No Diagnostic Substances) · Woburn, MA
REPL chart
What traders are saying about $REPL
Latest postsReplimune Group, Inc. news
- Replimune stock: Replimune schedules second-quarter results. What it means for Replimune stock
ad-hoc-news.de ·
- Replimune Group, Inc. Estimates – NASDAQ:REPL
TradingView ·
- Replimune Group Inc (7R8.DU) interactive stock chart
Yahoo Finance Australia ·
- Replimune (REPL.US) will release its financial report before the market opens on October 28.
Moomoo ·
- Replimune Group Inc (7R8.DU) Analyst insights, Price targets and Recommendations
Yahoo Finance Australia ·
- Replimune to Report the Fiscal Second Quarter 2027 Financial Results and Provide Corporate Update on October 28, 2026
Yahoo Finance ·
- REPL Q2'26 Earnings: revenue estimate is 0 USD
TradingView ·
- Replimune to report Q2 2027 financial results a...
Pluang ·
- Replimune Group (REPL) Stock Looks Rich After A 141% Run
Yahoo Finance ·
- Replimune Group (REPL) Launches TUDRIQEV As Its Valuation Story Comes Into Focus
Yahoo Finance ·
- Replimune Announces TUDRIQEV™ Now Available in the U.S. for Advanced Melanoma
Yahoo Finance ·
- Replimune to Present at the Cantor Global Healthcare Conference 2026
Yahoo Finance ·
Replimune Group, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Net income | -$313.9M | -$247.3M | -$215.8M | -$174.3M |
| Diluted EPS | $-3.38 | $-3.07 | $-3.24 | $-2.99 |
| Total assets (year end) | $333.6M | $603.6M | $532.9M | $678.5M |
| Cash and equivalents (year end) | $123.0M | $172.2M | $97.7M | $206.7M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Replimune Group, Inc.
- Ticker
- REPL (Nasdaq)
- Industry
- Biological Products, (No Diagnostic Substances)
- Headquarters
- Woburn, MA
- Incorporated in
- DE
- Fiscal year end
- March 31
- SEC CIK
- 1737953
Frequently asked questions
What exchange is Replimune Group, Inc. listed on?
Replimune Group, Inc. trades on the Nasdaq under the ticker symbol REPL.
What industry is Replimune Group, Inc. in?
Replimune Group, Inc. is classified by the SEC under "Biological Products, (No Diagnostic Substances)", part of the Healthcare sector on StockTweeting.
Where is Replimune Group, Inc. headquartered?
Replimune Group, Inc.'s business address on file with the SEC is in Woburn, MA.
When does Replimune Group, Inc.'s fiscal year end?
Replimune Group, Inc.'s fiscal year ends on March 31.